Recursion Pharmaceuticals Company
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
.png)
Investors
.png)
.png)
.png)
.jpeg)
(Reupload).png)
.png)
.jpg)
.png)
.png)
(Reupload).png)
.png)
(Reupload).png)
.png)
(Reupload).png)
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical, Therapeutics
Industry:
Drug Repurposing
Headquarters:
Salt Lake City, Utah, United States
Founded Date:
2013-11-05
Employees Number:
101-250
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
30
Total Funding:
465376000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-09-09
Last Funding Type:
Series D
Register and Claim Ownership